Delivery Order SPE2DB22D9112-SPE2DB25FTKML

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a Delivery Order under the SPE2DB program, valued at $3,603.10, for the supply of MENVEO A-C-Y-W KIT (2 VIALS). The contract has a period of performance through April 17, 2025 and is a Firm Fixed Price delivery order. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a $499,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, valued at $7,206.20, for the supply of MENVEO A-C-Y-W KIT (2 VIALS)S. The contract has an ultimate completion date of April 22, 2025 and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,467.32 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for MENVEO A-C-Y-W KIT (2 VIALS), valued at $3,898.80 with a completion date of August 10, 2023. The order was issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product, with a ceiling value of $9,357.12 and an ultimate completion date of August 10, 2023. The contract is a firm fixed-price delivery order and is not set aside for any particular business designation. DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $25,942.32 for the supply of Menveo A-C-Y-W immunization kits. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of MENVEO A-C-Y-W KIT (2 VIALS)S, a pharmaceutical product, with a ceiling value of $1,441.24 and an ultimate completion date of May 20, 2025. The contract was awarded on May 19, 2025 and does not have a set-aside designation. DMS Pharmaceutical...
This federal contract award with ID SPE2DB22D9353|SPE2DB25FX1VJ was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $3,603.10 firm fixed-price delivery order is for the supply of 4568023204 - MENVEO A-C-Y-W KIT (2 VIALS)S. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,112.04 firm fixed-price delivery order covers the supply of the Menveo vaccine. The contract is not associated with any set-aside designations. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This $27,477.72 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB25FTKML
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,080.93 firm fixed-price delivery order is for the supply of MENVEO A-C-Y-W KIT (2 VIALS), with a period of performance through May 22, 2025. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 8/20/25, 9:47 AM